Sculptra: A stimulatory filler

Facial Plastic Surgery

Volumn 25, Issue 2, 2009, Pages 95-99

  Lacombe, Victor ^a  

^a Facial Plastic and Reconstructive Surgery   (United States)

Author keywords

Filler; Lipoatrophy; PLLA; Poly L lactic acid; Sculptra

Indexed keywords

COLLAGEN; FENOFIBRATE; FILLER; HYALURONIC ACID; POLYLACTIC ACID;

BIOCOMPATIBILITY; CLINICAL TRIAL; HISTORY OF MEDICINE; HUMAN; LIPOATROPHY; ORBICULARIS OCULI MUSCLE; ORBICULARIS ORIS MUSCLE; PLASTIC SURGERY; PRACTICE GUIDELINE; REJUVENATION; REVIEW; SAFETY;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; CELLULOSE; CHONDROGENESIS; COSMETIC TECHNIQUES; FACE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MANNITOL; PATIENT SATISFACTION; REJUVENATION;

EID: 67649304948     PISSN: 07366825     EISSN: 10988793     Source Type: Journal    
DOI: 10.1055/s-0029-1220648     Document Type: Review

References (13)

1. Kates LC, Fitzgerald R. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principals, case studies and literature review. Aesthet Surg J 2008;28:397-403 (Pubitemid 352020659)
2. Lowe NJ. Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008;10:43-46 (Pubitemid 351360020)
3. Mest DR, Humble GM. Duration of correction for human immunodeficiency virus-associated lipoatrophy after retreatment with injectable poly-L-lactic acid. Aesthetic Plast Surg 2008; August 14 (Epub ahead of print)
4. Dermik Laboratories, Paris, France. Sculptra (injectable poly-L-lactic acid): a patient's guide to treatment with Sculptra. Dermik Laboratories; 2006
5. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg 2008;32:753-756
6. Burgess CM. Treatment of facial asymmetry with poly-L-lactic acid: a case study. Aesthetic Plast Surg 2008;32:552-554
7. Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoathrohy of aging with poly-L-lactic acid: a prospective 3-year follow up study. J Am Acad Dermatol 2008;59:923-933
8. Engelhard P, Humble G, Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 2005;7:201-205 (Pubitemid 43111922)
9. Rendon M. Injectable poly-L-lactic acid versus collagen: efficacy and safety in the correction of nasolabial fold wrinkles. Poster presented at: Sculptra Cosmetic Trial Group 31st Skin Disease Education Foundation; March 3-9, 2008 Maui, HI
10. Beer K. A single-center open label study on the use of poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg 2007;33(Suppl 2):S159-S167 (Pubitemid 350233455)
11. Schulman MR, Lipper J, Skolnik RA. Correction of chest wall deformity after implant based breast reconstruction using poly-L-lactic acid. (Sculptra). Breast J 2008;14:92-96
12. Grimaldi M, Gentile P, Labardi L, Silvi E, Trimarco A, Cervelli V. Lipostructure technique in Romberg syndrome. J Craniofac Surg 2008;19:1089-1091
13. Mest DR, Humble G. Efficacy and impact of retreatment with poly-L-lactic acid (PLLA) in persons with human immunodeficiency virus (HIV)-associated facial lipoatrphy. Poster presented at: American Academy of Dermatology 66th Annual Meeting; February 1-5 2008; San Antonio, TX